Found: 53
Select item for more details and to access through your institution.
Prevalence of delivery mode in an Italian nationwide cohort with celiac disease: a SIGENP multicenter retrospective study (the CD-deliver-IT).
- Published in:
- Italian Journal of Pediatrics, 2024, v. 50, n. 1, p. 1, doi. 10.1186/s13052-024-01710-0
- By:
- Publication type:
- Article
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 3, p. 404, doi. 10.3390/healthcare12030404
- By:
- Publication type:
- Article
Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3342, doi. 10.3390/cancers15133342
- By:
- Publication type:
- Article
Expression of p53 as a biomarker of pazopanib efficacy in solitary fibrous tumours: translational analysis of a phase II trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221116155
- By:
- Publication type:
- Article
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group.
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 1, p. 57, doi. 10.1007/s40272-021-00486-8
- By:
- Publication type:
- Article
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 11, p. 3041, doi. 10.1111/jgh.15590
- By:
- Publication type:
- Article
Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in Children.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1940, doi. 10.3390/jcm10091940
- By:
- Publication type:
- Article
Preliminary Evaluation of Plasmix Compound from Plastics Packaging Waste for Reuse in Bituminous Pavements.
- Published in:
- Sustainability (2071-1050), 2021, v. 13, n. 4, p. 2258, doi. 10.3390/su13042258
- By:
- Publication type:
- Article
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 6, p. 1064, doi. 10.1007/s10120-020-01078-0
- By:
- Publication type:
- Article
Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted.
- Published in:
- In Vivo, 2020, v. 34, n. 5, p. 2687, doi. 10.21873/invivo.12088
- By:
- Publication type:
- Article
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2049, doi. 10.3390/cancers12082049
- By:
- Publication type:
- Article
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 493, doi. 10.1007/s00432-019-03077-w
- By:
- Publication type:
- Article
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47627-1
- By:
- Publication type:
- Article
Inhaled nitric oxide as a rescue therapy in a preterm neonate with severe pulmonary hypertension: a case report.
- Published in:
- Italian Journal of Pediatrics, 2018, v. 44, n. 1, p. N.PAG, doi. 10.1186/s13052-018-0494-9
- By:
- Publication type:
- Article
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
- Published in:
- Oncology, 2016, v. 91, n. 5, p. 283, doi. 10.1159/000448004
- By:
- Publication type:
- Article
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06828
- By:
- Publication type:
- Article
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 438, doi. 10.1186/1471-2407-14-357
- By:
- Publication type:
- Article
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-357
- By:
- Publication type:
- Article
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.
- Published in:
- Journal of Cellular & Molecular Medicine, 2013, v. 17, n. 11, p. 1415, doi. 10.1111/jcmm.12109
- By:
- Publication type:
- Article
A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 3, p. 411, doi. 10.1007/s10120-012-0204-z
- By:
- Publication type:
- Article
Prospective Validation of Candidate SNPs of <i>VEGF/VEGFR</i> Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0066774
- By:
- Publication type:
- Article
Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 5, p. 1313, doi. 10.1007/s00520-012-1667-5
- By:
- Publication type:
- Article
Erratum to: Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study.
- Published in:
- Gastric Cancer, 2012, v. 15, n. 4, p. 419, doi. 10.1007/s10120-011-0134-1
- By:
- Publication type:
- Article
High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2012, v. 19, n. 3, p. 275, doi. 10.1007/s12282-009-0156-2
- By:
- Publication type:
- Article
High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease.
- Published in:
- Oncologist, 2012, v. 17, n. 6, p. 823, doi. 10.1634/theoncologist.2012-0081
- By:
- Publication type:
- Article
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients.
- Published in:
- Journal of Cellular Physiology, 2012, v. 227, n. 3, p. 927, doi. 10.1002/jcp.22801
- By:
- Publication type:
- Article
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 75, doi. 10.1159/000329079
- By:
- Publication type:
- Article
HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer.
- Published in:
- Histopathology, 2011, v. 58, n. 5, p. 669, doi. 10.1111/j.1365-2559.2011.03818.x
- By:
- Publication type:
- Article
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 247, doi. 10.1186/1471-2407-11-247
- By:
- Publication type:
- Article
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 2, p. 384, doi. 10.1002/jcp.22045
- By:
- Publication type:
- Article
VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.
- Published in:
- International Journal of Colorectal Disease, 2009, v. 24, n. 2, p. 165, doi. 10.1007/s00384-008-0586-x
- By:
- Publication type:
- Article
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice.
- Published in:
- Oncologist, 2008, v. 13, n. 12, p. 1270, doi. 10.1634/theoncologist.2008-0181
- By:
- Publication type:
- Article
Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review.
- Published in:
- American Journal of Epidemiology, 2008, v. 167, n. 5, p. 505
- By:
- Publication type:
- Article
A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population.
- Published in:
- BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-138
- By:
- Publication type:
- Article
A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 7, p. 822, doi. 10.1515/CCLM.2007.143
- By:
- Publication type:
- Article
Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 3, p. 628, doi. 10.1002/ijc.21397
- By:
- Publication type:
- Article
Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 6, p. 1010, doi. 10.1002/ijc.20489
- By:
- Publication type:
- Article
Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
- Published in:
- Oncogene, 2002, v. 21, n. 53, p. 8192, doi. 10.1038/sj.onc.1205921
- By:
- Publication type:
- Article
Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
- Published in:
- Human Mutation, 2002, v. 19, n. 5, p. 518, doi. 10.1002/humu.10067
- By:
- Publication type:
- Article
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.
- Published in:
- Clinical & Experimental Metastasis, 2000, v. 18, n. 8, p. 651, doi. 10.1023/A:1013133224044
- By:
- Publication type:
- Article
Author reply.
- Published in:
- Cancer (0008543X), 1999, v. 86, n. 3, p. 549, doi. 10.1002/(SICI)1097-0142(19990801)86:3<549::AID-CNCR31>3.0.CO;2-R
- By:
- Publication type:
- Article
Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma.
- Published in:
- Cancer (0008543X), 1998, v. 83, n. 9, p. 1917, doi. 10.1002/(SICI)1097-0142(19981101)83:9<1917::AID-CNCR6>3.0.CO;2-1
- By:
- Publication type:
- Article